Treatment with PF-04449913, an oral smoothened antagonist, in patients with myeloid malignancies: a phase 1 safety and pharmacokinetics study-Reference-Cited by-同舟云学术

Treatment with PF-04449913, an oral smoothened antagonist, in patients with myeloid malignancies: a phase 1 safety and pharmacokinetics study

Published:2015-08 Issue:8 Volume:2 Page:e339-e346
ISSN:2352-3026
Container-title:The Lancet Haematology
language:en
Short-container-title:The Lancet Haematology

Author:

Martinelli Giovanni,Oehler Vivian G,Papayannidis Cristina,Courtney Rachel,Shaik M Naveed,Zhang Xiaoxi,O'Connell Ashleigh,McLachlan Karen R,Zheng Xianxian,Radich Jerald,Baccarani Michele,Kantarjian Hagop M,Levin Wendy J,Cortes Jorge E,Jamieson Catriona

Publisher

Elsevier BV

Subject

Hematology

Reference28 articles.

1. Hedgehog signaling in animal development: paradigms and principles;Ingham;Genes Dev,2001

2. Molecular pathways: the hedgehog signaling pathway in cancer;McMillan;Clin Cancer Res,2012

3. Targeting hedgehog in hematologic malignancy;Irvine;Blood,2012

4. Hedgehog target genes: mechanisms of carcinogenesis induced by aberrant hedgehog signaling activation;Katoh;Curr Mol Med,2009

5. Essential role of stromally induced hedgehog signaling in B-cell malignancies;Dierks;Nat Med,2007

Cited by 105 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Glasdegib with intensive/nonintensive chemotherapy in Japanese patients with untreated acute myeloid leukemia or high‐risk myelodysplastic syndromes;Cancer Science;2024-02-07

2. Targeting cancer hallmark vulnerabilities in hematologic malignancies by interfering with Hedgehog/GLI signaling;Blood;2023-12-07

3. Physiologically Based Pharmacokinetic Modeling of the Drug–Drug Interaction Between CYP3A4 Substrate Glasdegib and Moderate CYP3A4 Inducers in Lieu of a Clinical Study;The Journal of Clinical Pharmacology;2023-10-18

4. Treating acute myelogenous leukemia in patients aged 70 and above: Recommendations from the International Society of Geriatric Oncology (SIOG);Journal of Geriatric Oncology;2023-09

5. Glasdegib for the treatment of acute myeloid leukemia;Expert Opinion on Pharmacotherapy;2023-07-03